Clinical Trials Using Birinapant

Clinical trials are research studies that involve people. The clinical trials on this list are studying Birinapant. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trials 1-3 of 3
  • Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients with Locally Recurrent Head and Neck Squamous Cell Carcinoma

    This phase I trial studies the side effects and best dose of birinapant when given together with intensity modulated re-irradiation therapy (IMRRT) in treating patients with head and neck squamous cell carcinoma that has come back at or near the same place as the original (primary) tumor. Drugs used in chemotherapy, such as birinapant, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. IMRRT uses thin beams of radiation of different intensities that are aimed at the tumor from many angles. This type of re-irradiation therapy reduces the damage to healthy tissue near the tumor. Giving birinapant with IMRRT may lower the chance of head and neck squamous cell carcinoma growing or spreading.
    Location: 3 locations

  • Dose-escalation Study of Birinapant and Pembrolizumab in Solid Tumors

    An ascending dose study in patients with solid tumors to evaluate the safety, tolerability, pharmacodynamics and efficacy of birinapant when given in combination with pembrolizumab. A dose expansion phase of 4 cohorts will also be included.
    Location: 3 locations

  • Birinapant and Carboplatin in Treating Patients with Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

    This phase I / II trial studies how well birinapant and carboplatin work in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has come back. Drugs used in chemotherapy, such as birinapant and carboplatin work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
    Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California